Robert Carson, MD, PhD

Dr. Carson's research has been focused on understanding disease mechanisms so that these mechanisms may be modulated to improve the quality of life of my patients. His experience with mTOR signaling led to a collaboration with Mark Grier in the lab of Dr. Andre Lagrange investigating myelination and mTOR signaling in Angelman syndrome model mice. Since that initial basic science exposure, his clinical focus has transitioned to the study of Angelman syndrome and Dup15q syndrome.

Moving forward, his focus is on generating a better understanding of epilepsy and nonepileptic myoclonus in Angelman syndrome. He has completed multiple industry-sponsored clinical trials in AS, one investigator-initiated clinical trial in AS, and currently has a grant from the Angelman Syndrome Foundation to study nonepileptic myoclonus in AS.

FAST Global Science Summit Presentations

• Hiding in Plain Sight: Dystonia in Angelman Syndrome

• Crowd-Sourcing Research into Nonepileptic Myoclunus in Angelman Syndrome